Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
La Noche de la Investigación
Científicos y científicas de toda Cataluña comparten su trabajo con charlas, talleres, demostraciones y juegos para todas las edades en…
ERC Public Engagement with Research Awards 2026
El Profesor de Investigación ICREA Karim Lekadir adscrito a la Universidad de Barcelona, ha sido galardonado con uno de los…